Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Opt Express ; 31(21): 34300-34312, 2023 Oct 09.
Artigo em Inglês | MEDLINE | ID: mdl-37859190

RESUMO

We employ a full-wave theory to systematically investigate two types of spin-orbit interactions and their topological phase transitions for various light beams (e.g., Laguerre-Gaussian, Bessel, and Bessel-Gaussian beams) at optical interfaces, and explore the influence of beam parameters on the spin-Hall shift. It is demonstrated that at small-angle incidence, the beam profile and spin-Hall shift are significantly affected by the beam parameters (e.g., waist radius, radial index, azimuthal index, and cone angle), whereas at large-angle incidence, only the azimuthal index has a salient influence on them. We further find that the Bessel beam and the Gaussian-modulated ones (i.e., Laguerre-Gaussian and Bessel-Gaussian beams) have similar topological phase transition phenomena but different shifts. Quantitative dependences of beam parameters, such as waist radius, radial index, azimuthal index, and cone angle, on the shift are also presented. Our findings offer alternative degrees of freedom in controlling the topological phase transitions of light, and suggest a valuable insight for exploring the applications of SOIs of diverse light fields.

2.
Sheng Li Xue Bao ; 75(3): 451-464, 2023 Jun 25.
Artigo em Zh | MEDLINE | ID: mdl-37340653

RESUMO

Serum and glucocorticoid-regulated kinase 1 (SGK1) plays an important role in the physiological processes of hormone release, neuronal excitation and cell proliferation. SGK1 also participates in the pathophysiological processes of inflammation and apoptosis in the central nervous system (CNS). Increasing evidence demonstrates that SGK1 may serve as a target of the intervention of neurodegenerative diseases. In this article, we summarize the recent progress on the role and molecular mechanisms of SGK1 in the regulation of the function of the CNS. We also discuss the potential of newly discovered SGK1 inhibitors in the treatment of CNS diseases.


Assuntos
Doenças do Sistema Nervoso Central , Proteínas Serina-Treonina Quinases , Humanos , Proliferação de Células , Doenças do Sistema Nervoso Central/tratamento farmacológico , Inflamação , Proteínas Serina-Treonina Quinases/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA